{
  "schemaType": "LegalCase",
  "title": "Talcum Powder / Ovarian Cancer",
  "shortName": "Talc",
  "slug": "talc",
  "canonicalUrl": "https://tortsignals.lawtegic.solutions/torts/talc",
  "description": "J&J's third bankruptcy attempt (LTL Management) was rejected in 2024. Talc litigation continues with active state and federal claims. Plaintiff bar split on settlement vs. trial strategy.",
  "body": "J&J's third bankruptcy attempt (LTL Management) was rejected in 2024. Talc litigation continues with active state and federal claims. Plaintiff bar split on settlement vs. trial strategy.",
  "tortSignalScore": 70,
  "opportunityScore": 65,
  "riskScore": 45,
  "mdl": "MDL 2738 (D.N.J.)",
  "docket": "MDL 2738 (D.N.J.)",
  "drugName": "Talc",
  "defendant": "Johnson & Johnson",
  "primaryInjury": "Ovarian cancer, mesothelioma",
  "jurisdictionLead": "New Jersey",
  "stage": "late",
  "campaign": "OPEN",
  "caseValueRange": "$100K – $400K (litigation) / $50K – $150K (settlement)",
  "litigationStatus": "MDL 2738 active in D.N.J. J&J's $9B settlement proposal under court review. Mesothelioma claims tried separately with strong plaintiff verdicts.",
  "attorneyAction": "Selective intake. Strong existing plaintiff bar competition. Best for firms with mesothelioma or existing J&J case experience.",
  "qualifies": "Women with documented long-term talcum powder use who developed ovarian cancer; individuals with mesothelioma diagnosis and talc exposure history.",
  "competition": "high",
  "recentNews": [
    {
      "date": "Apr 12, 2026",
      "source": "Reuters",
      "headline": "J&J's $9B talc settlement faces objections from plaintiff steering committee"
    },
    {
      "date": "Apr 05, 2026",
      "source": "Law360",
      "headline": "California jury awards $45M in mesothelioma talc case"
    }
  ],
  "faq": [
    {
      "q": "What is the talc lawsuit about?",
      "a": "Plaintiffs allege Johnson & Johnson's talcum powder products were contaminated with asbestos and caused ovarian cancer and mesothelioma."
    },
    {
      "q": "Who qualifies?",
      "a": "Women with long-term talc use diagnosed with ovarian cancer, and individuals with mesothelioma plus documented talc exposure."
    },
    {
      "q": "What is the case value?",
      "a": "Litigation values range from $100,000 to $400,000; J&J's proposed settlement framework offers $50,000 to $150,000."
    },
    {
      "q": "What is the litigation status?",
      "a": "MDL 2738 remains active. J&J's third bankruptcy attempt was rejected in 2024. A $9 billion settlement proposal is under court review."
    },
    {
      "q": "What should attorneys do?",
      "a": "Selective intake — competition from established plaintiff bar is high. Best fit for firms with mesothelioma or prior J&J experience."
    }
  ],
  "publisher": {
    "name": "LawTegic Solutions Media",
    "brand": "TortSignal",
    "url": "https://tortsignals.lawtegic.solutions"
  },
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "updatedAt": "2026-06-18T21:13:39.394Z"
}